tlooto
Sign up
Medicine

The Clinical Utility of MPO/PON1 and MPO/HDL-C Ratios in Cardiovascular Risk Assessment.

Wei-Jia Meng, Shang Zhu

2026.5.3THERAPEUTIC APHERESIS AND DIALYSIS

DOI: 10.1002/1744-9987.70152

Abstract

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

Citation format

MENG, Wei-Jia; ZHU, Shang. The clinical utility of MPO/PON1 and MPO/HDL-C ratios in cardiovascular risk assessment. THERAPEUTIC APHERESIS AND DIALYSIS, 2026.